Pterostilbene Purity, Trans-Isomer Identity and COA Review: A Buyer's Screening Guide
Disclosure: We may earn a commission if you purchase through links on this page, at no additional cost to you.
Quick Answer
A pterostilbene listing that says 98% or 99% is not yet a qualified raw material. The buyer still needs to confirm what the percentage measures, whether the material is trans-pterostilbene, which analytical method supports the result, what the remaining fraction contains and whether the COA belongs to the quoted lot. For a technical procurement decision, purity is only one part of identity and suitability.
The practical review sequence is: confirm chemical identity → verify the trans-isomer claim → examine the assay method and chromatogram or method basis → check impurities and contaminants → review moisture, residual solvents and package information → compare the COA with the specification → request a representative sample. This sequence is more reliable than selecting the highest headline percentage or the lowest price.
Why Pterostilbene Is Not a Complete Specification
Pterostilbene is a stilbene compound structurally related to resveratrol. Commercial material may be described as pterostilbene, trans-pterostilbene, blueberry extract, plant extract or a high-purity powder. Those descriptions do not necessarily represent the same quality level. An extract may contain a marker percentage alongside other plant constituents, while a purified ingredient is expected to have a defined chemical identity and a much narrower impurity profile.
The word trans matters because the geometric form is part of the identity claim. A supplier may use trans-pterostilbene as a product name without showing how the isomer was identified or quantified. A buyer should therefore request the CAS number, molecular formula, assay method, reference standard, retention-time evidence and, where relevant, an impurity or isomer profile. A single assay number without identity evidence is not enough for a high-value active.
| Listing language | What it may indicate | What the buyer still needs |
|---|---|---|
| Pterostilbene powder | A powder marketed under the compound name | CAS, identity, assay basis, method and batch COA |
| Trans-pterostilbene 98% | A stated isomer and purity claim | Evidence that trans material is identified and quantified specifically |
| Blueberry or botanical extract | A source or extract description | Marker definition, extract ratio, carrier, full composition and contaminants |
| 99% purity | A high headline assay | Method specificity, reference standard, chromatogram or method validation basis |
Check Identity Before Discussing Purity
The first document review should establish whether the supplier is offering the intended substance. Record the product name, CAS number, molecular formula, molecular weight, appearance and stated source. Then compare those details across the product page, TDS, SDS and COA. Inconsistencies are not automatically proof of failure, but they are a reason to stop and request clarification before ordering.
For a purified pterostilbene ingredient, the COA should not rely only on generic plant extract language. If the commercial name says trans-pterostilbene but the COA reports only a broad polyphenol or total extract marker, the document does not support the same identity claim. The supplier should explain the relationship between the botanical source, purification process and final assay.
| Identity check | Acceptable evidence | Warning signal |
|---|---|---|
| Chemical name and CAS | Consistent information across COA, TDS and SDS | Different names or CAS numbers across documents |
| Isomer claim | A method capable of distinguishing or specifically quantifying the trans form | Trans appears only in the marketing title |
| Appearance | A defined description such as white or off-white powder, with lot data | Appearance is missing or changes without explanation |
| Source and process | Clear statement of extraction, purification or synthesis route | Source is described only as natural or herbal |
Understand What the Assay Percentage Actually Means
A stated 98% or 99% can be reported on an as-is basis, dry basis or another calculation basis. Moisture and volatile content can materially change the comparison. Ask whether the assay is w/w, whether water is corrected, whether the result is calculated against a reference standard and whether the specification is a release limit or simply a typical value.
The method also matters. HPLC with a suitable standard and system suitability information generally provides a more useful starting point for a purified small molecule than a nonspecific total-polyphenol assay. UV detection may be part of an HPLC method, but HPLC/UV alone does not tell the buyer the column, mobile phase, retention-time identification, resolution, standardisation or impurity handling. Request enough method information to understand what was measured.
| COA field | Buyer question | Why it matters |
|---|---|---|
| Assay result | Is it as-is or dry basis? | Prevents false comparison between lots and suppliers |
| Test method | Which standard, column and detection method were used? | Shows whether the method is specific enough for the claim |
| Specification | Is 98% a minimum, a typical result or a target? | Separates contractual acceptance from promotional wording |
| Batch number | Does the COA match the sample and package? | Links the document to the material being purchased |
| Test date and retest date | How old is the evidence and how is shelf life assigned? | Helps judge whether the result remains representative |
Review the Impurity and Contaminant Profile
High assay does not automatically mean a low-risk ingredient. The remaining fraction may include related compounds, residual solvents, moisture, process aids, inorganic residues or botanical contaminants. The appropriate panel depends on the route and market, but a serious RFQ should ask how the supplier controls related substances and process residues.
For a botanical-derived material, request heavy metals, pesticide residues, microbial limits and any relevant mycotoxin or solvent information. For a purified or synthetic route, ask about residual solvents, related substances, catalyst or reagent residues and the control of geometric isomers. The supplier does not need to use the same specification as every market, but the buyer needs a transparent basis for deciding whether additional testing is required.
- Related substances and unidentified impurities, preferably with reporting and identification thresholds.
- Residual solvents matched to the declared extraction or purification process.
- Heavy metals and elemental impurities with a stated test method.
- Pesticide residues and microbiological limits when a botanical source is claimed.
- Moisture or loss on drying, ash where relevant, and foreign matter.
- Allergen, GMO, irradiation and animal-origin statements when required by the target product.
Treat the COA as a Lot Document, Not a Brochure
A COA becomes useful when it is traceable to a real lot. Check the lot number, manufacturing date, retest or expiry date, quantity, package and sign-off. Compare the result against the specification and look for repeated identical values across unrelated lots. A set of perfectly identical numbers may be possible, but it can also indicate a template rather than a batch-specific test record.
If the supplier sends a generic COA before sampling, label it as preliminary evidence. After receiving a sample, compare colour, odour, powder behaviour and analytical identity with the document. For a high-purity active, consider independent confirmation of identity and assay before approving the supplier for a production order. The purpose is not to duplicate every supplier test automatically; it is to verify the risk that matters to the application.
| COA review step | What to record | Decision |
|---|---|---|
| Document traceability | Supplier, product code, lot, dates and package | Reject or clarify if the lot cannot be linked |
| Identity consistency | CAS, name, formula, appearance and method | Escalate contradictions before sampling |
| Assay and impurities | Result, limits, basis and method | Compare on a common basis |
| Sample correlation | Sample label, seal, appearance and lot | Do not qualify a different lot silently |
| Independent check | Selected identity, assay or contaminant tests | Use where material value or risk justifies it |
Current Sourcing Entries
This article intentionally uses one product-level sourcing entry and one separately supplied supplier storefront option. The links are procurement leads, not evidence that the material has passed independent qualification.
The supplier storefront option was supplied by the buying team for this article. Product and supplier links are kept separate so their roles are clear.
Evaluate Storage and Package Information
Pterostilbene powder should be evaluated as a chemical material, not only as a static assay number. Ask how the supplier controls light, humidity, oxygen exposure and package headspace. A powder may remain visually acceptable while absorbing moisture, changing flow or developing a measurable assay trend. The proposed inner bag, outer drum, desiccant use and resealing instructions should be recorded.
Request the supplier's shelf-life or retest basis and confirm whether it applies to the package being quoted. If the material will be opened repeatedly in a development laboratory, include an in-use handling plan. At minimum, retain the original lot information, keep a sealed reserve sample and document any opening, repacking or environmental excursion.
Supplier Qualification Should Be Evidence-Weighted
Alibaba store age is a useful screening signal, but it should not be treated as an automatic pass or fail. The more important questions are whether the supplier can answer technical questions, provide coherent documents, supply a representative sample and explain differences between extract, purified and trans-isomer grades. A long operating history with vague documentation is not enough; a newer supplier with strong traceability may still merit a controlled screen.
- Can the supplier explain the product route and whether it is extract, purified natural material or synthetic?
- Can the supplier provide a lot-specific COA rather than a generic template?
- Can the supplier state the trans-isomer basis and provide method details?
- Can the supplier supply TDS, SDS, residual-solvent and contaminant information?
- Can the supplier provide a sample linked to the quoted specification?
- Does the supplier communicate changes to process, package, specification or manufacturing site?
Buyer Decision
The right pterostilbene purchase is not the listing with the largest percentage. It is the lot whose identity, trans-isomer claim, assay basis, impurity profile, package and documentation all line up with the intended use. A disciplined COA review catches the most expensive mistakes early: buying a botanical extract as if it were a purified active, comparing dry-basis and as-is results as though they were equal, or treating a generic document as a lot release record.
Use the following decision path: confirm identity → verify trans-isomer evidence → normalise the assay basis → review related substances and contaminants → inspect lot traceability → sample and independently check the highest-risk attributes. Only then should price, MOQ and lead time determine the final shortlist.
References
- Rimando AM, Cuyaubère R, Bayet C, et al. Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. Journal of Agricultural and Food Chemistry. 2002;50(12):3453-3457. doi:10.1021/jf0116855.
- McCormack D, McFadden D. A review of pterostilbene antioxidant activity and disease modification. Oxidative Medicine and Cellular Longevity. 2013;2013:575482. doi:10.1155/2013/575482.
- Paul S, et al. Pterostilbene: a natural compound with pharmacological potential. Current Medicinal Chemistry. 2010;17(17):1819-1830.
- International Council for Harmonisation. Q2(R2) Validation of Analytical Procedures. Official guideline.
- International Council for Harmonisation. Q3C(R8) Impurities: Guideline for Residual Solvents. Official guideline.
- United States Pharmacopeia. General Chapter <467> Residual Solvents. Official compendial chapter.
Related content
Continue exploring related ingredient research and sourcing guides.
Creatine Monohydrate 200 Mesh vs Micronized: What Buyers Should Verify
A 200-mesh claim and the word micronized are both shorthand. What each one can and cannot tell you, when sieve analysis is enough, and how to write a particle-size limit that a lot has to meet.
80 Mesh vs 200 Mesh Creatine Monohydrate: How Buyers Should Specify Particle Size
Mesh is a sieve shorthand, not a specification. How to make 80 and 200 mesh comparable, test dispersion at the intended dose, and write a particle-size limit into the RFQ.
L-Carnitine L-Tartrate COA: How to Read a 99% Assay and a 68% L-Carnitine Result
A salt assay near 99% and an L-carnitine result near 68% can describe the same pure material. How to name the analyte, the basis and the method so a COA actually releases a lot.
L-Theanine COA Checklist for Ingredient Buyers
A 98% HPLC result is only the headline. How to tie the L-theanine COA to a lot, read the assay basis, and keep L-form evidence separate from a routine non-chiral assay.